Kevin Liu

Bortezomib Plus Melphalan and Prednisone Compared With Melphalan and Prednisone in Previously Untreated Multiple Myeloma: Updated Follow-Up and Impact of Subsequent Therapy in the Phase III VISTA Trial

María‐Victoria Mateos, Paul G. Richardson, Rudolf Schlag et al. · Journal of Clinical Oncology · 2010 · 431 citations · Full text

Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed patients with multiple myeloma: subanalysis of the phase 3 VISTA study

Meletios Α. Dimopoulos, María-Victoria Mateos, Paul G. Richardson et al. · European Journal Of Haematology · 2010 · 145 citations

Exploring topical anti-glaucoma medication effects on the ocular surface in the context of the current understanding of dry eye

Aaron B C Wong, Michael T.M. Wang, Kevin Liu et al. · The Ocular Surface · 2018 · 59 citations

Ocular Disease, Dry Eye, Ophthalmology +6

Herpes Zoster Ophthalmicus Clinical Presentation and Risk Factors for Loss of Vision

Jay J. Meyer, Kevin Liu, Helen V. Danesh‐Meyer · American Journal of Ophthalmology · 2021 · 52 citations

Ocular Disease, Ophthalmology, Ocular Pathology +3

Updated Follow-up and Results of Subsequent Therapy in the Phase III VISTA Trial: Bortezomib Plus Melphalan–Prednisone Versus Melphalan–Prednisone in Newly Diagnosed Multiple Myeloma

Jesús F. San Miguel, Rudolf Schlag, Nuriet K. Khuageva et al. · Blood · 2008 · 35 citations